Director, Regional Ecosystem Lead (US Northeast)

Benefits

Additional Information

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Director, Regional Ecosystem Lead (US Northeast)? The job is in our Waltham MA Office. This is a hybrid position and is onsite three days a week. Position Description Summary Serve as CSL's key leader in the key innovation hubs to enhance the CSL external brand leading to BD deal flow to grow our pipeline. These senior leaders will combine ecosystem engagement, strategic scouting, and deal team leadership to ensure CSL maintains a strong presence and pipeline of opportunities across biotech, academia, and investment networks. This role partners with global R&D;, business development, and legal teams to strengthen the organization's innovation pipeline and competitive advantage. The individual will leverage deep internal organizational knowledge, align with the GLG, and internal subject matter experts (SMEs) to position CSL as the partner of choice in the key ecosystems of biotech innovation. Main Responsibilities & Accountabilities Serve as the key CSL leader within the regional innovation ecosystem, actively sourcing opportunities aligned with all TA strategies and portfolio priorities. Create new partnership opportunities for GLG presence within each ecosystem. Maintain and expand strategic relationships with universities, incubators, accelerators, venture capital firms, and local organizations to amplify CSL's external innovation priorities. Partner closely with TA Search Leads to conduct regional searches, plan engagements and conferences, and share regional insights and updates. Serve as a senior member of deal teams occurring in each region, supporting transactions from identification through due diligence and help lead relationships with external partners through deal close. Organize and represent CSL at local external innovation events, such as CSL-hosted innovation days, and ensure strong visibility in the ecosystem. Actively participate as a board member in key industry bodies and associations (e.g., MassBio , AusBiotech , Californai Bio, etc.) and pursue board or committee memberships to influence industry direction and strengthen networks. Maintain intimate knowledge of internal organizational capabilities, priorities, and SMEs and engage internal experts to enhance credibility and reputation externally. Provide insights on regional biotech trends, competitive landscape, and innovation hotspots. Work closely with R&D; BD, and legal teams to evaluate and integrate external assets. Qualifications & Experience Requirements 12+ years in biopharma, external innovation, or business development with strong regional network and ecosystem knowledge. Advanced degree required (PhD, MD, or equivalent). Proven track record of enhancing Pharma senior leadership presence/reputation as a partner of choice in biotech ecosystems to drive BD deal flow. Proven ability to source and evaluate external opportunities and lead deal execution. Strong relationship-building skills with academic, biotech, and investment communities. The expected base salary range for this position at hiring is $232,000 - $284,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity. #LI-HYBRID About CSL Behring CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ .